r.hu-erythropoietin (EPO) treatment of pre-ESRD patients slows the rate of progression of renal decline
about
Effect of methoxy polyethylene glycol-epoetin beta on oxidative stress in predialysis patients with chronic kidney disease.Restricted Use of Erythropoiesis-Stimulating Agent is Safe and Associated with Deferred Dialysis Initiation in Stage 5 Chronic Kidney Disease.Off the beaten renin-angiotensin-aldosterone system pathway: new perspectives on antiproteinuric therapy.Effect of erythropoietin therapy on red cells filterability and left ventricular mass in predialysis patients.
P2860
r.hu-erythropoietin (EPO) treatment of pre-ESRD patients slows the rate of progression of renal decline
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
r.hu-erythropoietin (EPO) trea ...... f progression of renal decline
@ast
r.hu-erythropoietin (EPO) trea ...... f progression of renal decline
@en
r.hu-erythropoietin (EPO) trea ...... f progression of renal decline
@nl
type
label
r.hu-erythropoietin (EPO) trea ...... f progression of renal decline
@ast
r.hu-erythropoietin (EPO) trea ...... f progression of renal decline
@en
r.hu-erythropoietin (EPO) trea ...... f progression of renal decline
@nl
prefLabel
r.hu-erythropoietin (EPO) trea ...... f progression of renal decline
@ast
r.hu-erythropoietin (EPO) trea ...... f progression of renal decline
@en
r.hu-erythropoietin (EPO) trea ...... f progression of renal decline
@nl
P2093
P2860
P356
P1433
P1476
r.hu-erythropoietin (EPO) trea ...... f progression of renal decline
@en
P2093
Manuel Perera-Chong
Mihály Tapolyai
Satoshi Kadomatsu
P2860
P2888
P356
10.1186/1471-2369-4-3
P407
P577
2003-06-17T00:00:00Z
P5875
P6179
1053052913